According to a new report from Intel Market Research, the global Ustekinumab Biosimilars market was valued at USD 1.5 billion in 2025 and is projected to reach USD 3.2 billion by 2034, growing at a CAGR of 8.7% during the forecast period (2026–2034). This substantial growth reflects increasing demand for cost-effective biologic alternatives to treat autoimmune disorders like psoriasis,...
Global Demand Outlook for Executive Summary Erythropoietin (EPO) Drugs Market Size and Share
CAGR Value
The global erythropoietin (EPO) drugs market size was valued at USD 9.12 billion in 2024 and is expected to reach USD 22.60 billion by 2032, at a CAGR of 12.00% during the forecast period
Global Erythropoietin (EPO) Drugs Market report is a...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek